NLS Pharmaceutics Correlations
| NLSPW Stock | USD 0.01 0 18.18% |
The current 90-days correlation between NLS Pharmaceutics and Lumos Pharma is 0.26 (i.e., Modest diversification). The correlation of NLS Pharmaceutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
NLS Pharmaceutics Correlation With Market
Good diversification
The correlation between NLS Pharmaceutics AG and DJI is -0.11 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding NLS Pharmaceutics AG and DJI in the same portfolio, assuming nothing else is changed.
NLS |
Moving against NLS Stock
| 0.52 | INTC | Intel Fiscal Year End 23rd of January 2025 | PairCorr |
| 0.47 | CAT | Caterpillar Fiscal Year End 3rd of February 2025 | PairCorr |
| 0.44 | DD | Dupont De Nemours Fiscal Year End 4th of February 2025 | PairCorr |
| 0.43 | HD | Home Depot | PairCorr |
| 0.38 | GE | GE Aerospace Fiscal Year End 28th of January 2025 | PairCorr |
| 0.37 | AA | Alcoa Corp Fiscal Year End 15th of January 2025 | PairCorr |
| 0.33 | CVX | Chevron Corp Fiscal Year End 7th of February 2025 | PairCorr |
| 0.31 | HPQ | HP Inc | PairCorr |
Related Correlations Analysis
| 0.86 | -0.55 | 0.8 | -0.68 | ELYM | ||
| 0.86 | -0.54 | 0.7 | -0.58 | SCPH | ||
| -0.55 | -0.54 | -0.39 | 0.51 | MIST | ||
| 0.8 | 0.7 | -0.39 | -0.63 | MCRB | ||
| -0.68 | -0.58 | 0.51 | -0.63 | LUMO | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between NLS Stock performing well and NLS Pharmaceutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze NLS Pharmaceutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ELYM | 3.92 | (0.78) | 0.00 | 0.73 | 0.00 | 6.21 | 34.87 | |||
| SCPH | 2.64 | (0.84) | 0.00 | (0.35) | 0.00 | 4.05 | 20.70 | |||
| MIST | 1.90 | 0.19 | 0.12 | 0.24 | 1.61 | 7.19 | 18.66 | |||
| MCRB | 4.93 | 0.19 | 0.02 | 0.60 | 5.66 | 10.84 | 28.84 | |||
| LUMO | 2.44 | 0.38 | 0.06 | (0.43) | 2.72 | 5.95 | 16.25 |